CSCs were characterized for the first time in acute myeloid leukemia (AML), in which cells with the CD34+/CD38− phenotype exhibited proliferative and self-renewal capacities similar to those of primary stem cells [18]. Here, CD38 is linked to acute myeloid leukemia.